U.S. federal trademark · Serial No. 97661045
Pharmaceutical preparations for the treatment of COVID 19, coronaviruses, and respiratory and infectious diseases; Pharmaceuticals, namely, prodrugs, protein fusion compounds and inhibitors for the treatment of COVID-19, coronaviruses, and respiratory and infectious diseases; Antiviral prodrugs
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.